Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL255787 (A-740003) |
---|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
P2X7/P2X purinoceptor 7 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4805] [GtoPdb: 484] [UniProtKB: Q99572] | ||||||||
ChEMBL | Antagonist activity at human P2X7R expressed in HEK293 cells assessed as inhibition of ATP-induced ethidium iodide uptake preincubated for 5 mins followed by ATP induction and measured after 25 mins by fluorescence assay | B | 6.12 | pIC50 | 750 | nM | IC50 | Bioorg Med Chem (2019) 27: 1449-1455 [PMID:30528164] |
ChEMBL | Antagonist activity at human recombinant P2X7 receptor expressed in human THP1 cells assessed as inhibition of BzATP-induced IL1-beta release by enzyme-linked immunosorbent assay | F | 6.81 | pIC50 | 156 | nM | IC50 | Bioorg. Med. Chem. (2009) 17: 4861-4865 [PMID:19540765] |
ChEMBL | Antagonist activity at human P2X7R expressed in HEK293 cells assessed as inhibition of ATP-induced ethidium iodide uptake preincubated for 10 mins followed by ATP induction measured after 25 mins by fluorescence assay | B | 6.96 | pIC50 | 109 | nM | IC50 | Eur J Med Chem (2018) 143: 1361-1372 [PMID:29133043] |
ChEMBL | Antagonist activity at human recombinant P2X7 receptor expressed in human 1321N1 cells assessed as inhibition of BzATP-induced pore formation flux by fluorometric assay | F | 7.04 | pIC50 | 92 | nM | IC50 | Bioorg. Med. Chem. (2009) 17: 4861-4865 [PMID:19540765] |
ChEMBL | Antagonist activity at human P2X7 receptor | B | 7.05 | pIC50 | 90 | nM | IC50 | J Med Chem (2016) 59: 7410-7430 [PMID:27427902] |
ChEMBL | Antagonist activity at P2X7 receptor in LPS/IFNc-differentiated human THP-1 cells assessed as inhibition of ATP-induced IL-1beta release preincubated for 30 mins followed by LPS stimulation for 4 hrs using cells treated with ATP for 30 mins by ELISA | B | 7.05 | pIC50 | 89 | nM | IC50 | Eur J Med Chem (2017) 139: 698-717 [PMID:28858765] |
ChEMBL | Antagonist activity at human P2X7 receptor expressed in HEK293 cells assessed as inhibition of ATP-induced ethidium iodide uptake preincubated for 10 mins followed by ATP addition measured after 20 mins by spectrofluorometric analysis | B | 7.07 | pIC50 | 86 | nM | IC50 | Eur J Med Chem (2017) 139: 698-717 [PMID:28858765] |
ChEMBL | Antagonist activity at human P2X7 receptor expressed in HEK293 cells assessed as inhibition of ATP-induced IL-1beta release preincubated for 30 mins followed by ATP addition measured after 30 mins by ELISA | B | 7.09 | pIC50 | 82 | nM | IC50 | Eur J Med Chem (2017) 139: 698-717 [PMID:28858765] |
ChEMBL | Antagonist activity at human recombinant P2X7 receptor assessed as inhibition of calcium flux by FLIPR assay | F | 7.36 | pIC50 | 44 | nM | IC50 | Bioorg. Med. Chem. Lett. (2008) 18: 2093-2096 [PMID:18272365] |
ChEMBL | Antagonist activity at human recombinant P2X7 receptor expressed in human 1321N1 cells assessed as inhibition of agonist-induced calcium flux by fluorometric assay | F | 7.4 | pIC50 | 40 | nM | IC50 | Bioorg. Med. Chem. (2009) 17: 4861-4865 [PMID:19540765] |
GtoPdb | - | - | 7.4 | pIC50 | 40 | nM | IC50 | J Pharmacol Exp Ther (2006) 319: 1376-85 [PMID:16982702] |
ChEMBL | Antagonist activity at P2X7 receptor in human THP1 cells assessed as inhibition of BzATP-induced ethidium uptake | F | 7.4 | pIC50 | 39.81 | nM | IC50 | J. Med. Chem. (2009) 52: 3123-3141 [PMID:19191585] |
ChEMBL | Antagonist activity at human cloned P2X7 receptor expressed in HEK293 cells assessed as inhibition of calcium flux by FLIPR assay | F | 7.4 | pIC50 | 39.81 | nM | IC50 | J. Med. Chem. (2009) 52: 3366-3376 [PMID:19397270] |
P2X7/P2X purinoceptor 7 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5183] [GtoPdb: 484] [UniProtKB: Q9Z1M0] | ||||||||
ChEMBL | Antagonist activity at P2X7R in Swiss Webster mouse peritoneal macrophages assessed as inhibition of ATP-induced propidium iodide uptake preincubated for 10 mins followed by ATP induction measured after 25 mins by fluorescence assay | B | 6.05 | pIC50 | 897 | nM | IC50 | Eur J Med Chem (2018) 143: 1361-1372 [PMID:29133043] |
ChEMBL | Antagonist activity at P2X7 receptor in LPS/IFNc-differentiated Swiss mouse peritoneal macrophages assessed as inhibition of ATP-induced IL-1beta release preincubated for 30 mins followed by LPS stimulation for 4 hrs using cells treated with ATP for 15 mins by ELISA | B | 6.95 | pIC50 | 112 | nM | IC50 | Eur J Med Chem (2017) 139: 698-717 [PMID:28858765] |
ChEMBL | Antagonist activity at P2X7 receptor in Swiss mouse peritoneal macrophages assessed as inhibition of BzATP-induced ethidium iodide uptake after 30 mins by spectrofluorometric analysis | B | 7.2 | pIC50 | 63.33 | nM | IC50 | Eur J Med Chem (2017) 139: 698-717 [PMID:28858765] |
ChEMBL | Antagonist activity at P2X7 receptor in Swiss mouse peritoneal macrophages assessed as inhibition of BzATP-induced current at holding potential of -60 mV preincubated for 5 mins followed by BzATP addition measured after 5 mins by Whole cell patch-clamp analysis | B | 7.33 | pIC50 | 46.91 | nM | IC50 | Eur J Med Chem (2017) 139: 698-717 [PMID:28858765] |
P2X7/P2X purinoceptor 7 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2496] [GtoPdb: 484] [UniProtKB: Q64663] | ||||||||
ChEMBL | Antagonist activity at rat cloned P2X7 receptor expressed in HEK293 cells assessed as inhibition of calcium flux by FLIPR assay | F | 7.7 | pIC50 | 19.95 | nM | IC50 | J. Med. Chem. (2009) 52: 3366-3376 [PMID:19397270] |
ChEMBL | Activity at rat P2X7 receptor expressed in HEK cells assessed as effect on BzATP-induced ethidium uptake | B | 7.7 | pIC50 | 19.95 | nM | IC50 | J. Med. Chem. (2009) 52: 3123-3141 [PMID:19191585] |
ChEMBL | Antagonist activity at rat recombinant P2X7 receptor assessed as inhibition of calcium flux by FLIPR assay | F | 7.74 | pIC50 | 18 | nM | IC50 | Bioorg. Med. Chem. Lett. (2008) 18: 2093-2096 [PMID:18272365] |
ChEMBL | Antagonist activity at rat recombinant P2X7 receptor expressed in human 1321N1 cells assessed as inhibition of agonist-induced calcium flux by fluorometric assay | F | 7.74 | pIC50 | 18 | nM | IC50 | Bioorg. Med. Chem. (2009) 17: 4861-4865 [PMID:19540765] |
ChEMBL data shown on this page come from version 31:
Gaulton A, Hersey A, Nowotka M, Bento AP, Chambers J, Mendez D, Mutowo P, Atkinson F, Bellis LJ, CibriƔn-Uhalte E, Davies M, Dedman N, Karlsson A, MagariƱos MP, Overington JP, Papadatos G, Smit I, Leach AR. (2017) 'The ChEMBL database in 2017.' Nucleic Acids Res., 45(D1). DOI: 10.1093/nar/gkw1074. [PMCID:5210557]